Multisystem Inflammatory Syndrome in Adult after First Dose of mRNA Vaccine.

Miyazato, Yusuke; Yamamoto, Kei; Yamada, Gen; Kubota, Shuji; Ishikane, Masahiro; Sugiyama, Masaya; Ueno, Mikako; Matsunaga, Akihiro; Miyoshi-Akiyama, Tohru; Ishizaka, Yukihito; Ohmagari, Norio

Miyazato, Yusuke; Yamamoto, Kei; Yamada, Gen; Kubota, Shuji; Ishikane, Masahiro; Sugiyama, Masaya; Ueno, Mikako; Matsunaga, Akihiro; Miyoshi-Akiyama, Tohru; Ishizaka, Yukihito; Ohmagari, Norio.

Emerg Infect Dis ; 28(4): 870-872, 2022 04.

Article in En | MEDLINE | ID: mdl-35148495

Subject(s)

COVID-19 Vaccines; COVID-19; Adult; COVID-19/prevention & control; COVID-19 Vaccines/adverse effects; Humans; Male; SARS-CoV-2; Vaccines, Synthetic; mRNA Vaccines

Key words

COVID-19; Japan; MIS-A; SARS-CoV-2; anti-nucleocapsid antibody; anti-spike antibody; coronavirus disease; cytokine profile; hyperinflammatory state; multisystem inflammatory syndrome; myocardial injury; respiratory failure; severe acute respiratory syndrome coronavirus 2; vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Limits: Adult / Humans / Male Language: En Journal: Emerg Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google